Catalyst Wire Dossier Catalyst Wire Dossier

Tiotropium Respimat

tiotropium · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Tiotropium Respimat, covering 2011-04-13 to 2016-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma [Phase 3]

See pricing